| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.49 | 0.03 |